These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 37474063)
1. Exposure to per- and polyfluoroalkyl substances in early pregnancy and risk of cerebral palsy in children. Vilhelmsson A; Rylander L; Jöud A; Lindh CH; Mattsson K; Liew Z; Guo P; Ritz B; Källén K; Thacher JD Sci Total Environ; 2023 Nov; 899():165622. PubMed ID: 37474063 [TBL] [Abstract][Full Text] [Related]
2. [Determination of seven perfluoroalkyl and polyfluoroalkyl substances in serum of pregnant women and evaluation of neonatal neurobehavior based on high performance liquid chromatography-tandem mass spectrometry]. Wang ZH; Liang FZ; Chen XR; Wu P; Wu W Se Pu; 2024 Feb; 42(2):194-202. PubMed ID: 38374600 [TBL] [Abstract][Full Text] [Related]
3. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances. Crawford L; Halperin SA; Dzierlenga MW; Skidmore B; Linakis MW; Nakagawa S; Longnecker MP Environ Int; 2023 Feb; 172():107734. PubMed ID: 36764183 [TBL] [Abstract][Full Text] [Related]
4. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women. Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666 [TBL] [Abstract][Full Text] [Related]
5. Prenatal exposure to per- and polyfluoroalkyl substances and pregnancy outcome in Austria. Kaiser AM; Forsthuber M; Widhalm R; Granitzer S; Weiss S; Zeisler H; Foessleitner P; Salzer H; Grasl-Kraupp B; Moshammer H; Hartmann C; Uhl M; Gundacker C Ecotoxicol Environ Saf; 2023 Jul; 259():115006. PubMed ID: 37182303 [TBL] [Abstract][Full Text] [Related]
6. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children. Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314 [TBL] [Abstract][Full Text] [Related]
7. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort. Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208 [TBL] [Abstract][Full Text] [Related]
8. Maternal Plasma Perfluoroalkyl Substances and Miscarriage: A Nested Case-Control Study in the Danish National Birth Cohort. Liew Z; Luo J; Nohr EA; Bech BH; Bossi R; Arah OA; Olsen J Environ Health Perspect; 2020 Apr; 128(4):47007. PubMed ID: 32319790 [TBL] [Abstract][Full Text] [Related]
9. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and neurobehavior in US children through 8 years of age: The HOME study. Vuong AM; Webster GM; Yolton K; Calafat AM; Muckle G; Lanphear BP; Chen A Environ Res; 2021 Apr; 195():110825. PubMed ID: 33545124 [TBL] [Abstract][Full Text] [Related]
10. Associations between per- and polyfluoroalkyl substances, liver function, and daily alcohol consumption in a sample of U.S. adults. Ma X; Fisher JA; VoPham T; Vasiliou V; Jones RR Environ Res; 2023 Oct; 235():116651. PubMed ID: 37451576 [TBL] [Abstract][Full Text] [Related]
11. Association between per- and polyfluoroalkyl substances exposure and prevalence of chronic obstructive pulmonary disease: The mediating role of serum albumin. Wang Y; Zhang J; Zhang J; Hou M; Kong L; Lin X; Xu J; Yan C; Lin F; Ke S Sci Total Environ; 2024 May; 925():171742. PubMed ID: 38494022 [TBL] [Abstract][Full Text] [Related]
12. Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project Viva Cohort: A mixtures approach. Preston EV; Webster TF; Claus Henn B; McClean MD; Gennings C; Oken E; Rifas-Shiman SL; Pearce EN; Calafat AM; Fleisch AF; Sagiv SK Environ Int; 2020 Jun; 139():105728. PubMed ID: 32311629 [TBL] [Abstract][Full Text] [Related]
13. Prenatal exposure to 11 perfluoroalkyl substances and fetal growth: A large-scale, prospective birth cohort study. Kashino I; Sasaki S; Okada E; Matsuura H; Goudarzi H; Miyashita C; Okada E; Ito YM; Araki A; Kishi R Environ Int; 2020 Mar; 136():105355. PubMed ID: 32029284 [TBL] [Abstract][Full Text] [Related]
14. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013-2014. Jackson-Browne MS; Eliot M; Patti M; Spanier AJ; Braun JM Int J Hyg Environ Health; 2020 Aug; 229():113565. PubMed ID: 32485600 [TBL] [Abstract][Full Text] [Related]
15. Higher free thyroxine associated with PFAS exposure in first trimester. The Odense Child Cohort. Jensen RC; Glintborg D; Timmermann CAG; Nielsen F; Boye H; Madsen JB; Bilenberg N; Grandjean P; Jensen TK; Andersen MS Environ Res; 2022 Sep; 212(Pt D):113492. PubMed ID: 35597289 [TBL] [Abstract][Full Text] [Related]
16. Human serum poly- and perfluoroalkyl substance concentrations and their associations with gestational diabetes mellitus. Zhang Y; Chen R; Gao Y; Qu J; Wang Z; Zhao M; Bai X; Jin H Environ Pollut; 2023 Jan; 317():120833. PubMed ID: 36493933 [TBL] [Abstract][Full Text] [Related]
17. Associations of prenatal exposure to perfluoroalkyl substances with preterm birth: A family-based birth cohort study. Yu Y; Qin XD; Bloom MS; Chu C; Dai X; Li QQ; Chen ZX; Kong ML; Xie YQ; Meng WJ; Yang BY; Hu LW; Zeng XW; Zhao XM; Zhou Y; Dong GH Environ Res; 2022 Nov; 214(Pt 1):113803. PubMed ID: 35810818 [TBL] [Abstract][Full Text] [Related]
18. Association between in utero perfluoroalkyl substance exposure and anti-Müllerian hormone levels in adolescent females in a British cohort. Donley GM; Taylor E; Jeddy Z; Namulanda G; Hartman TJ Environ Res; 2019 Oct; 177():108585. PubMed ID: 31376627 [TBL] [Abstract][Full Text] [Related]
19. Prenatal perfluoroalkyl substances exposure and maternal sex steroid hormones across pregnancy. Rivera-Núñez Z; Kinkade CW; Khoury L; Brunner J; Murphy H; Wang C; Kannan K; Miller RK; O'Connor TG; Barrett ES Environ Res; 2023 Mar; 220():115233. PubMed ID: 36621543 [TBL] [Abstract][Full Text] [Related]
20. Gestational and childhood exposure to per- and polyfluoroalkyl substances and cardiometabolic risk at age 12 years. Li N; Liu Y; Papandonatos GD; Calafat AM; Eaton CB; Kelsey KT; Cecil KM; Kalkwarf HJ; Yolton K; Lanphear BP; Chen A; Braun JM Environ Int; 2021 Feb; 147():106344. PubMed ID: 33418195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]